Foundation Medicine has started the “Quality First” initiative to create awareness of how “not all cancer biomarker tests are created equal.”
Source: FiercePharma
You may also like
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
Organ Aging Linked to Breakdown in Immune Cell...
Biotronik Neuro snaps up spinal cord stimulation...
Why Commercial Evidence Is the Next Breakthrough in...
Operating at the speed of science: The new medical...
Why modern clinical trials need a finance-first...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.